Mandate

Vinge advises the major shareholders of Eco-Boråstapeter in connection with sale to Litorina

September 13, 2010

Vinge has advised the major shareholders of Eco-Boråstapeter in connection with the sale of their shares to Litorina. Eco-Boråstapeter is one of the leading wallpaper manufacturers in the Nordic countries. Litorina has acquired approximately two-thirds of the company’s shares and is thus the new majority shareholder. The new company’s shareholder base will also include members of the company’s board of directors and approximately 135 of Eco-Boråstapeter’s former employees. Eco-Boråstapeter had a turnover of approximately SEK 550 million in 2009 and has approximately 165 employees.

Vinge’s team consisted of responsible partner Björn Nicolai and associates Shoan Panahi, Viggo Becker-Ståhl and Gabriel Westin.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026